Sort
11,323 grants matching “glioblastoma”
Innovative Nose-to-Brain Anticancer Drug Transport Facilitated by NEO100
$300,000Thomas C Chen · Neonc Technologies, Inc. · R41 · FY2018 · CA
Collaborative Research: Chimeric Antigen Receptor Engineered Neutrophil Extracellular Vesicles Targeting Glioblastoma
$300,000Xiaoping Bao · Purdue University · · FY2025 · ENG
PRODUCTION OF ALTERNATIVE FGF RECEPTOR FORMS IN TUMORS
$300,000University Of Texas Md Anderson Can Ctr · R01 · FY2000 · CA
Targeting glioblastoma stem-like cells with custom-designed viral vectors
$300,000Kenneth H Warrington · Lacerta Therapeutics, Inc. · R42 · FY2018 · CA
Chemically produced neural progenitors as a delivery vehicle for anti-glioma therapy
$300,000Arshak R Alexanian · Cell Reprogramming And Therapeutics, Llc · R43 · FY2018 · CA
Development of Small Molecule SUMO1 Inhibitors for Treatment of Glioblastoma
$300,000Anita Bellail · Hb Therapeutics, Inc. · R43 · FY2018 · CA
Project Glioblastoma CARE: Cellular Analysis of Resistance and Evolution (2)
$299,999Laurie H Glimcher · Dana-Farber Cancer Inst · P30 · FY2021 · CA
BIOTHERAPY OF BRAIN TUMORS BY RADIOIODINATED SAPC-DOPS NANOVESICLES
$299,989Brian D. Gray · Molecular Targeting Technologies, Inc. · N43 · FY2017 · CA
Design of a micro-RNA attenuated armed oHSV for the treatment of glioblastoma
$299,976Christophe Queva · Oncorus, Inc. · R43 · FY2019 · CA
Role of LRP in Astrocytoma Migration
$299,958Isa M Hussaini · University Of Virginia · R01 · FY2007 · NS
An Improved Intra-Arterial Delivery Platform for Glioblastoma Multiforme
$299,946Francis Milton Creighton · Unandup, Llc · R43 · FY2020 · CA
A Novel Brachytherapy Agent for GBM
$299,937Thomas C Chen · Applied Integrin Sciences, Inc. · R41 · FY2013 · CA
TOPIC 382 - THE MICROSCOPIC IMAGING OF EPIGENETIC LANDSCAPE BREAST TUMOR DIFFERENTIATION (MIEL-BTD) ASSAY: A HIGH THROUGHPUT SCREEN TO IDENTIFY NOVEL THERAPEUTICS FOR BREAST CANCER.
$299,923Patrick McDonough · Vala Sciences, Inc. · N43 · FY2019 · CA
Core 2: Animal and Pharmacology
$299,875Jann N Sarkaria · Massachusetts Institute Of Technology · U54 · FY2017 · CA
MDA-7/IL-24: Therapy of Malignant Glioma
$299,856Paul Dent · Virginia Commonwealth University · P01 · FY2009 · CA
Biophysical Control of Cell Form and Function by Single Actomyosin Stress Fibers
$299,736Sanjay Kumar · University Of California Berkeley · R01 · FY2017 · GM
Regulation of PTEN Activity in Cancer Cells
$299,712University Of Arizona · R01 · FY2004 · CA
Project 2: Combined personal neoantigen-targeting cancer vaccines with immune checkpoint blockade for ovarian cancer
$299,639Panagiotis Konstantinopoulos · Dana-Farber Cancer Inst · P50 · FY2021 · CA
Signal Transduction and Tumor Angiogenesis
$299,625Kevin M Pumiglia · Albany Medical College · R01 · FY2007 · CA
Signal Transduction and Tumor Angiogenesis
$299,625Kevin M Pumiglia · Albany Medical College · R01 · FY2008 · CA
HSP27: A modulator and therapeutic target of SPARC-induced glioma invasion.
$299,552Sandra Ann Rempel · Corewell Health · R01 · FY2015 · CA
Imaging and Tissue Biomarkers for Improved Management of Patients with Newly Diag
$299,402Sarah J. Nelson · University Of California, San Francisco · P01 · FY2010 · CA
Research Testbed 2
$299,397David J Odde · University Of Minnesota · U54 · FY2025 · CA
Novel role of STAT3 in NPM/ALK-induced oncogenesis
$299,362Mariusz A Wasik · University Of Pennsylvania · R01 · FY2009 · CA
Novel role of STAT3 in NPM/ALK-induced oncogenesis
$299,362Mariusz A Wasik · University Of Pennsylvania · R01 · FY2010 · CA